The term refers to an eating pattern that complements GLP-1 medications by helping you meet your nutritional needs, manage side effects, and support healthy weight loss
But now scientists are raising concerns that are likely to surprise both patients and physicians: possible bone fractures and even vision problems
These results provide clues to neural mechanisms that support the development of GLP- 1 and GIP combination therapeutics for the treatment of obesity and DM [79]
"A negative trial result may indicate lack of drug access to the brain, rather than failure of the concept itself," Paul Edison, a professor of neuroscience at Imperial College London, explained.
Injectable forms provide higher bioavailability and more consistent results, while oral forms offer convenience but reduced efficiency
Once inside the mitochondria, these fats are oxidizedor burnedto create usable energy